Phase I and pharmacokinetic study of ABI-007, albumin-bound paclitaxel, administered every 3 weeks in Japanese patients with solid tumors
about
Albumin-Bound Paclitaxel: A Review in Non-Small Cell Lung Cancer.Nab-paclitaxel for the treatment of breast cancer: efficacy, safety, and approval.Phase I study of weekly nab-paclitaxel combined with S-1 in patients with human epidermal growth factor receptor type 2-negative metastatic breast cancer.Treatment of recurrent and platinum-refractory stage IV non-small cell lung cancer with nanoparticle albumin-bound paclitaxel (nab-paclitaxel) as a single agent.Clinical Pharmacokinetics of Paclitaxel Monotherapy: An Updated Literature Review.Meta-analysis of nanoparticulate paclitaxel delivery system pharmacokinetics and model prediction of associated neutropenia.Efficacy and safety of Abraxane in treatment of progressive and recurrent non-small cell lung cancer patients: A retrospective clinical study.Evaluation of the effect of compression therapy using surgical gloves on nanoparticle albumin-bound paclitaxel-induced peripheral neuropathy: a phase II multicenter study by the Kamigata Breast Cancer Study Group.A phase II, multicenter, single-arm study of tri-weekly low-dose nanoparticle albumin-bound paclitaxel chemotherapy for patients with metastatic or recurrent breast cancer.Assessing the clinical outcome of nab-paclitaxel in Chinese patients with advanced non-small-cell lung cancer.A phase I study of S-1 in combination with nab-paclitaxel in patients with unresectable or recurrent gastric cancer.
P2860
Q33427359-CB3ACE29-0C38-4A81-A2BE-EF55140E4A3FQ35128729-1B9C24EB-EDFB-4995-ADCF-6AF6B7E9C7C9Q35754251-BD0B42FF-F371-4B34-878E-BBD46D8EA3D3Q37119741-B1FADA97-A9C5-482B-BE13-8A71342E359BQ38726616-588ABD13-46B8-48CB-9880-4369A5BE4C15Q46811884-D78D8001-458B-4AE6-AC0C-84CF53AF9D18Q50050270-4C517F49-4B56-48BE-9C1A-F456F77DA7F5Q50229022-5EBF1794-33E3-4423-9BE4-B79BAB4B87B1Q50441875-FE5FCD48-CC08-4BB3-BBE4-4C4D5FC88B71Q51591928-59F00B7A-F437-4CEF-A442-9AAF145C3C0FQ53099235-308DB4EB-1686-47FC-B24C-6DFE03B0A719
P2860
Phase I and pharmacokinetic study of ABI-007, albumin-bound paclitaxel, administered every 3 weeks in Japanese patients with solid tumors
description
2010 nî lūn-bûn
@nan
2010 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Phase I and pharmacokinetic st ...... ese patients with solid tumors
@ast
Phase I and pharmacokinetic st ...... ese patients with solid tumors
@en
type
label
Phase I and pharmacokinetic st ...... ese patients with solid tumors
@ast
Phase I and pharmacokinetic st ...... ese patients with solid tumors
@en
prefLabel
Phase I and pharmacokinetic st ...... ese patients with solid tumors
@ast
Phase I and pharmacokinetic st ...... ese patients with solid tumors
@en
P2093
P2860
P356
P1476
Phase I and pharmacokinetic st ...... ese patients with solid tumors
@en
P2093
Hironobu Minami
Kazuhiko Yamada
Noboru Yamamoto
Tomohide Tamura
Toru Mukohara
Yasuhide Yamada
P2860
P304
P356
10.1093/JJCO/HYP192
P577
2010-02-04T00:00:00Z